Myriad Genetics, Inc. (MYGN)

Iznogoud888 (85.79) Submitted: 7/02/08 3:16 PM : Start Price: $52.83 MYGN Score: -43.53

Failed PIII Flurizan for AD and actually shot up on the news - Possibly because of new focus on successful molecular diagnostics business. However, the enthusiasm has gone a little too high as the stock is now trading at more that 75 times 2009E earnings.

Report this Post Replies: 0 | Reply | Permalink